These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 11254118

  • 1. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials.
    Huncharek M, Caubet JF, McGarry R.
    Melanoma Res; 2001 Feb; 11(1):75-81. PubMed ID: 11254118
    [Abstract] [Full Text] [Related]

  • 2. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH, Atzpodien J, Poliwoda H.
    Med Klin (Munich); 1996 Apr 12; 91 Suppl 3():44-9. PubMed ID: 8692119
    [Abstract] [Full Text] [Related]

  • 3. Prospective randomized comparison of dacarbazine (DTIC) versus DTIC plus interferon-alpha (IFN-alpha) in metastatic melanoma.
    Young AM, Marsden J, Goodman A, Burton A, Dunn JA.
    Clin Oncol (R Coll Radiol); 2001 Apr 12; 13(6):458-65. PubMed ID: 11824887
    [Abstract] [Full Text] [Related]

  • 4. Treatment of metastatic malignant melanoma.
    Atallah E, Flaherty L.
    Curr Treat Options Oncol; 2005 May 12; 6(3):185-93. PubMed ID: 15869730
    [Abstract] [Full Text] [Related]

  • 5. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
    Atzpodien J, Lopez Hänninen E, Kirchner H, Franzke A, Körfer A, Volkenandt M, Duensing S, Schomburg A, Chaitchik S, Poliwoda H.
    Eur J Cancer; 1995 Jun 12; 31A(6):876-81. PubMed ID: 7646914
    [Abstract] [Full Text] [Related]

  • 6. Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma.
    Xin Y, Huang Q, Zhang P, Yang M, Hou XY, Tang JQ, Zhang LZ, Jiang G.
    Medicine (Baltimore); 2016 Apr 12; 95(16):e3406. PubMed ID: 27100429
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ, Falkson G.
    Med Pediatr Oncol; 1975 Apr 12; 1(2):107-11. PubMed ID: 1228411
    [Abstract] [Full Text] [Related]

  • 11. Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group.
    Punt CJ, Suciu S, Gore MA, Koller J, Kruit WH, Thomas J, Patel P, Lienard D, Eggermont AM, Keilholz U.
    Eur J Cancer; 2006 Nov 12; 42(17):2991-5. PubMed ID: 17023156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and side effects of dacarbazine in comparison with temozolomide in the treatment of malignant melanoma: a meta-analysis consisting of 1314 patients.
    Teimouri F, Nikfar S, Abdollahi M.
    Melanoma Res; 2013 Oct 12; 23(5):381-9. PubMed ID: 23880781
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
    Thatcher D, Lind M, Morgenstern G, Carr T, Chadwick G, Jones R, Craig P.
    Cancer; 1989 Apr 01; 63(7):1296-302. PubMed ID: 2646005
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of melanoma].
    Dréno B, Wallon-Dumont G.
    Presse Med; 2003 Jan 11; 32(1):39-43. PubMed ID: 12610396
    [Abstract] [Full Text] [Related]

  • 20. Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanoma.
    Hillner BE, Agarwala S, Middleton MR.
    J Clin Oncol; 2000 Apr 11; 18(7):1474-80. PubMed ID: 10735895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.